_id
6911c07accc777a4e85d637c
Ticker
GSGTF
Name
GenSight Biologics S.A
Exchange
PINK
Address
74, rue du Faubourg Saint-Antoine, Paris, France, 75012
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.gensight-biologics.com
Description
GenSight Biologics S.A., a clinical-stage biotechnology company, discovers, develops, and commercializes novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system. The company develops its products through gene therapy-based mitochondrial targeting sequence and optogenetics technology platforms. Its lead product candidates include LUMEVOQ, a recombinant AAV2-based gene therapy, which is in Phase III clinical trials for the treatment of leber hereditary optic neuropathy caused by a mutated ND4 gene; and GS030, which is in Phase I/II clinical trial for the treatment of retinitis pigmentosa and dry age-related macular degeneration. The company is also developing products that are in preclinical stage targeting ophthalmic and neurodegenerative diseases. It has license agreements with Sorbonne Université, CNRS, Inserm and SATT Lutech; Inserm Transfert S.A, Genethon, and Harvard; Massachusetts Institute of Technology; Novartis Pharma AG; Sorbonne University, Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale and Satt Lutech; Association Française contre les Myopathies, Inserm Transfert S.A; and non-exclusive license agreement with Adverum Biotechnologies. The company was incorporated in 2012 and is headquartered in Paris, France.
Last Close
0.1901
Volume
-
Current Price
0.1901
Change
0
Last Updated
2026-01-03T12:59:58.259Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
36124524
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
48000
Cost Of Revenue
-
Gross Profit
48000
Operating Expenses
6838000
Operating Income
-8313075
Interest Expense
2553882
Pretax Income
-8533359
Net Income
-6967000
Eps
-0.054314282379852745
Dividends Per Share
-
Shares Outstanding
190029052
Income Tax Expense
-325125
EBITDA
-5861678
Operating Margin
-17318.90625
Total Other Income Expense Net
-220284
Cash
318057
Short Term Investments
-
Receivables
1000
Inventories
-
Total Current Assets
2714000
Property Plant Equipment
695000
Total Assets
7351000
Payables
10088306
Short Term Debt
13957000
Long Term Debt
-
Total Liabilities
39457000
Equity
-32106000
Bs_currency_symbol
-
Depreciation
172000
Change In Working Capital
4940490
Cash From Operations
-3153479
Capital Expenditures
0
Cash From Investing
-62433
Cash From Financing
623156
Net Change In Cash
-2232725
Cf_currency_symbol
-
PE
-
PB
-0.7594998285990157
ROE
21.699993770634773
ROA
-94.77622092232349
FCF
-3153479
Fcf Percent
-65.69747916666667
Piotroski FScore
1
Health Score
31
Deep Value Investing Score
0.5
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
6.3
Garp Investing Score
2
Growth Investing Score
1.5
Momentum Investing Score
3.5
Net Net Investing Score
0.5
Quality Investing Score
2
Value Investing Score
2.5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
48000
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
48000
Quarters > 0 > income Statement > operating Expenses
6838000
Quarters > 0 > income Statement > operating Income
-8313075
Quarters > 0 > income Statement > interest Expense
2553882
Quarters > 0 > income Statement > pretax Income
-8533359
Quarters > 0 > income Statement > net Income
-6967000
Quarters > 0 > income Statement > eps
-0.054314282379852745
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
128271970
Quarters > 0 > income Statement > income Tax Expense
-325125
Quarters > 0 > income Statement > EBITDA
-5861678
Quarters > 0 > income Statement > operating Margin
-17318.90625
Quarters > 0 > income Statement > total Other Income Expense Net
-220284
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
318057
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
1000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
2714000
Quarters > 0 > balance Sheet > property Plant Equipment
695000
Quarters > 0 > balance Sheet > total Assets
7351000
Quarters > 0 > balance Sheet > payables
10088306
Quarters > 0 > balance Sheet > short Term Debt
13957000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
39457000
Quarters > 0 > balance Sheet > equity
-32106000
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-6967000
Quarters > 0 > cash Flow > depreciation
172000
Quarters > 0 > cash Flow > change In Working Capital
4940490
Quarters > 0 > cash Flow > cash From Operations
-3153479
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-62433
Quarters > 0 > cash Flow > cash From Financing
623156
Quarters > 0 > cash Flow > net Change In Cash
-2232725
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.054314282379852745
Quarters > 0 > ratios > PB
-0.7594998285990157
Quarters > 0 > ratios > ROE
21.699993770634773
Quarters > 0 > ratios > ROA
-94.77622092232349
Quarters > 0 > ratios > FCF
-3153479
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-65.69747916666667
Quarters > 0 > health Score
31
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
-228000
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-228000
Quarters > 1 > income Statement > operating Expenses
8182000
Quarters > 1 > income Statement > operating Income
-8410000
Quarters > 1 > income Statement > interest Expense
621000
Quarters > 1 > income Statement > pretax Income
-8138000
Quarters > 1 > income Statement > net Income
-8153000
Quarters > 1 > income Statement > eps
-0.09852629056177714
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
82749487
Quarters > 1 > income Statement > income Tax Expense
16000
Quarters > 1 > income Statement > EBITDA
-4027000
Quarters > 1 > income Statement > operating Margin
3688.5964912280697
Quarters > 1 > income Statement > total Other Income Expense Net
272000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
2464000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
1000
Quarters > 1 > balance Sheet > inventories
-1000
Quarters > 1 > balance Sheet > total Current Assets
5343000
Quarters > 1 > balance Sheet > property Plant Equipment
933000
Quarters > 1 > balance Sheet > total Assets
10756000
Quarters > 1 > balance Sheet > payables
6357000
Quarters > 1 > balance Sheet > short Term Debt
13899000
Quarters > 1 > balance Sheet > long Term Debt
0
Quarters > 1 > balance Sheet > total Liabilities
37676000
Quarters > 1 > balance Sheet > equity
-26920000
Quarters > 1 > balance Sheet > currency_symbol
EUR
Quarters > 1 > cash Flow > net Income
-8153000
Quarters > 1 > cash Flow > depreciation
-371000
Quarters > 1 > cash Flow > change In Working Capital
786000
Quarters > 1 > cash Flow > cash From Operations
-5592000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
5000
Quarters > 1 > cash Flow > cash From Financing
1407000
Quarters > 1 > cash Flow > net Change In Cash
-4476000
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.09852629056177714
Quarters > 1 > ratios > PB
-0.5843490891047548
Quarters > 1 > ratios > ROE
30.28603268945022
Quarters > 1 > ratios > ROA
-75.79955373744886
Quarters > 1 > ratios > FCF
-5592000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
24.526315789473685
Quarters > 1 > health Score
49
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
1728000
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
1728000
Quarters > 2 > income Statement > operating Expenses
9131000
Quarters > 2 > income Statement > operating Income
-7403000
Quarters > 2 > income Statement > interest Expense
932000
Quarters > 2 > income Statement > pretax Income
-5843000
Quarters > 2 > income Statement > net Income
-5848000
Quarters > 2 > income Statement > eps
-0.07067113298237124
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
82749487
Quarters > 2 > income Statement > income Tax Expense
5000
Quarters > 2 > income Statement > EBITDA
-7342000
Quarters > 2 > income Statement > operating Margin
-428.4143518518518
Quarters > 2 > income Statement > total Other Income Expense Net
1560000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
6940000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
35000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
13016000
Quarters > 2 > balance Sheet > property Plant Equipment
1385000
Quarters > 2 > balance Sheet > total Assets
14986000
Quarters > 2 > balance Sheet > payables
4784000
Quarters > 2 > balance Sheet > short Term Debt
6665000
Quarters > 2 > balance Sheet > long Term Debt
10258000
Quarters > 2 > balance Sheet > total Liabilities
39820000
Quarters > 2 > balance Sheet > equity
-24834000
Quarters > 2 > balance Sheet > currency_symbol
EUR
Quarters > 2 > cash Flow > net Income
-5848000
Quarters > 2 > cash Flow > depreciation
1430000
Quarters > 2 > cash Flow > change In Working Capital
87000
Quarters > 2 > cash Flow > cash From Operations
-7345000
Quarters > 2 > cash Flow > capital Expenditures
1000
Quarters > 2 > cash Flow > cash From Investing
12000
Quarters > 2 > cash Flow > cash From Financing
12135000
Quarters > 2 > cash Flow > net Change In Cash
6940000
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.07067113298237124
Quarters > 2 > ratios > PB
-0.6334330948981235
Quarters > 2 > ratios > ROE
23.54836111782234
Quarters > 2 > ratios > ROA
-39.023088215667954
Quarters > 2 > ratios > FCF
-7346000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-4.251157407407407
Quarters > 2 > health Score
30
Quarters > 3 > quarter
2024-03-31
Quarters > 3 > income Statement > revenue
864000
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
864000
Quarters > 3 > income Statement > operating Expenses
4565500
Quarters > 3 > income Statement > operating Income
-3701500
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-2921500
Quarters > 3 > income Statement > net Income
-2924000
Quarters > 3 > income Statement > eps
-0.03533556649118562
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
82749487
Quarters > 3 > income Statement > income Tax Expense
2500
Quarters > 3 > income Statement > EBITDA
-3671000
Quarters > 3 > income Statement > operating Margin
-428.4143518518518
Quarters > 3 > income Statement > total Other Income Expense Net
780000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
6940000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
35000
Quarters > 3 > balance Sheet > inventories
1051000
Quarters > 3 > balance Sheet > total Current Assets
13016000
Quarters > 3 > balance Sheet > property Plant Equipment
1385000
Quarters > 3 > balance Sheet > total Assets
14986000
Quarters > 3 > balance Sheet > payables
4784000
Quarters > 3 > balance Sheet > short Term Debt
6665000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
39820000
Quarters > 3 > balance Sheet > equity
-24834000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-2924000
Quarters > 3 > cash Flow > depreciation
286500
Quarters > 3 > cash Flow > change In Working Capital
43500
Quarters > 3 > cash Flow > cash From Operations
-3672500
Quarters > 3 > cash Flow > capital Expenditures
500
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
6067500
Quarters > 3 > cash Flow > net Change In Cash
2403000
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.03533556649118562
Quarters > 3 > ratios > PB
-0.6334330948981235
Quarters > 3 > ratios > ROE
11.77418055891117
Quarters > 3 > ratios > ROA
-19.511544107833977
Quarters > 3 > ratios > FCF
-3673000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-4.251157407407407
Quarters > 3 > health Score
23
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
1500000
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
1500000
Annuals > 0 > income Statement > operating Expenses
17313000
Annuals > 0 > income Statement > operating Income
-15813000
Annuals > 0 > income Statement > interest Expense
1553000
Annuals > 0 > income Statement > pretax Income
-13981000
Annuals > 0 > income Statement > net Income
-14001000
Annuals > 0 > income Statement > eps
-0.16919742354414838
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
82749487
Annuals > 0 > income Statement > income Tax Expense
21000
Annuals > 0 > income Statement > EBITDA
-11369000
Annuals > 0 > income Statement > operating Margin
-1054.2
Annuals > 0 > income Statement > total Other Income Expense Net
1832000
Annuals > 0 > income Statement > currency_symbol
EUR
Annuals > 0 > balance Sheet > cash
2464000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
1000
Annuals > 0 > balance Sheet > inventories
-1000
Annuals > 0 > balance Sheet > total Current Assets
5343000
Annuals > 0 > balance Sheet > property Plant Equipment
933000
Annuals > 0 > balance Sheet > total Assets
10756000
Annuals > 0 > balance Sheet > payables
6357000
Annuals > 0 > balance Sheet > short Term Debt
13899000
Annuals > 0 > balance Sheet > long Term Debt
0
Annuals > 0 > balance Sheet > total Liabilities
37676000
Annuals > 0 > balance Sheet > equity
-26920000
Annuals > 0 > balance Sheet > currency_symbol
EUR
Annuals > 0 > cash Flow > net Income
-14001000
Annuals > 0 > cash Flow > depreciation
1059000
Annuals > 0 > cash Flow > change In Working Capital
873000
Annuals > 0 > cash Flow > cash From Operations
-12937000
Annuals > 0 > cash Flow > capital Expenditures
1000
Annuals > 0 > cash Flow > cash From Investing
17000
Annuals > 0 > cash Flow > cash From Financing
13542000
Annuals > 0 > cash Flow > net Change In Cash
330000
Annuals > 0 > cash Flow > currency_symbol
EUR
Annuals > 0 > ratios > PE
-0.16919742354414838
Annuals > 0 > ratios > PB
-0.5843490891047548
Annuals > 0 > ratios > ROE
52.00965824665676
Annuals > 0 > ratios > ROA
-130.16920788397172
Annuals > 0 > ratios > FCF
-12938000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-8.625333333333334
Annuals > 0 > health Score
30
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
1267000
Annuals > 1 > income Statement > cost Of Revenue
-1733000
Annuals > 1 > income Statement > gross Profit
1267000
Annuals > 1 > income Statement > operating Expenses
30963000
Annuals > 1 > income Statement > operating Income
-29696000
Annuals > 1 > income Statement > interest Expense
3153000
Annuals > 1 > income Statement > pretax Income
-27917000
Annuals > 1 > income Statement > net Income
-26220000
Annuals > 1 > income Statement > eps
-0.5426735663892084
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
48316339
Annuals > 1 > income Statement > income Tax Expense
-1696000
Annuals > 1 > income Statement > EBITDA
-20890000
Annuals > 1 > income Statement > operating Margin
-2343.804262036306
Annuals > 1 > income Statement > total Other Income Expense Net
3475000
Annuals > 1 > income Statement > currency_symbol
EUR
Annuals > 1 > balance Sheet > cash
2134000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
1000
Annuals > 1 > balance Sheet > inventories
2722000
Annuals > 1 > balance Sheet > total Current Assets
6529000
Annuals > 1 > balance Sheet > property Plant Equipment
2025000
Annuals > 1 > balance Sheet > total Assets
9132000
Annuals > 1 > balance Sheet > payables
5634000
Annuals > 1 > balance Sheet > short Term Debt
17380000
Annuals > 1 > balance Sheet > long Term Debt
0
Annuals > 1 > balance Sheet > total Liabilities
39834000
Annuals > 1 > balance Sheet > equity
-30668000
Annuals > 1 > balance Sheet > currency_symbol
EUR
Annuals > 1 > cash Flow > net Income
-26220000
Annuals > 1 > cash Flow > depreciation
2179000
Annuals > 1 > cash Flow > change In Working Capital
2454000
Annuals > 1 > cash Flow > cash From Operations
-24663000
Annuals > 1 > cash Flow > capital Expenditures
10000
Annuals > 1 > cash Flow > cash From Investing
209000
Annuals > 1 > cash Flow > cash From Financing
15859000
Annuals > 1 > cash Flow > net Change In Cash
-8476000
Annuals > 1 > cash Flow > currency_symbol
EUR
Annuals > 1 > ratios > PE
-0.5426735663892084
Annuals > 1 > ratios > PB
-0.2994957624853267
Annuals > 1 > ratios > ROE
85.49628277031434
Annuals > 1 > ratios > ROA
-287.12220762155056
Annuals > 1 > ratios > FCF
-24673000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-19.47355958958169
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
2582000
Annuals > 2 > income Statement > cost Of Revenue
0.5
Annuals > 2 > income Statement > gross Profit
2582000
Annuals > 2 > income Statement > operating Expenses
30417000
Annuals > 2 > income Statement > operating Income
-27835000
Annuals > 2 > income Statement > interest Expense
2650000
Annuals > 2 > income Statement > pretax Income
-27619000
Annuals > 2 > income Statement > net Income
-27624000
Annuals > 2 > income Statement > eps
-0.5962404346891493
Annuals > 2 > income Statement > dividends Per Share
6372268
Annuals > 2 > income Statement > shares Outstanding
46330303
Annuals > 2 > income Statement > income Tax Expense
5000
Annuals > 2 > income Statement > EBITDA
-26774000
Annuals > 2 > income Statement > operating Margin
-1078.0402788536019
Annuals > 2 > income Statement > total Other Income Expense Net
215000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
10610000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
3490000
Annuals > 2 > balance Sheet > inventories
8482000
Annuals > 2 > balance Sheet > total Current Assets
22947000
Annuals > 2 > balance Sheet > property Plant Equipment
2268000
Annuals > 2 > balance Sheet > total Assets
25941000
Annuals > 2 > balance Sheet > payables
7813000
Annuals > 2 > balance Sheet > short Term Debt
2429000
Annuals > 2 > balance Sheet > long Term Debt
9246000
Annuals > 2 > balance Sheet > total Liabilities
41220000
Annuals > 2 > balance Sheet > equity
-15279000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-27625000
Annuals > 2 > cash Flow > depreciation
1061000
Annuals > 2 > cash Flow > change In Working Capital
-3916000
Annuals > 2 > cash Flow > cash From Operations
-33753000
Annuals > 2 > cash Flow > capital Expenditures
252000
Annuals > 2 > cash Flow > cash From Investing
172000
Annuals > 2 > cash Flow > cash From Financing
95000
Annuals > 2 > cash Flow > net Change In Cash
-33679000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.5962404346891493
Annuals > 2 > ratios > PB
-0.5764376333726029
Annuals > 2 > ratios > ROE
180.79717258982916
Annuals > 2 > ratios > ROA
-106.4877992367295
Annuals > 2 > ratios > FCF
-34005000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-13.170023237800155
Annuals > 2 > health Score
31
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
5276000
Annuals > 3 > income Statement > cost Of Revenue
0.64
Annuals > 3 > income Statement > gross Profit
5276000
Annuals > 3 > income Statement > operating Expenses
33401000
Annuals > 3 > income Statement > operating Income
-28126000
Annuals > 3 > income Statement > interest Expense
2166000
Annuals > 3 > income Statement > pretax Income
-28615000
Annuals > 3 > income Statement > net Income
-28617000
Annuals > 3 > income Statement > eps
-0.633812287555388
Annuals > 3 > income Statement > dividends Per Share
358797.36
Annuals > 3 > income Statement > shares Outstanding
45150592
Annuals > 3 > income Statement > income Tax Expense
2000
Annuals > 3 > income Statement > EBITDA
-27199000
Annuals > 3 > income Statement > operating Margin
-533.0932524639879
Annuals > 3 > income Statement > total Other Income Expense Net
-489000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
44288000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
754000
Annuals > 3 > balance Sheet > inventories
4368000
Annuals > 3 > balance Sheet > total Current Assets
53363000
Annuals > 3 > balance Sheet > property Plant Equipment
2549000
Annuals > 3 > balance Sheet > total Assets
56648000
Annuals > 3 > balance Sheet > payables
11561000
Annuals > 3 > balance Sheet > short Term Debt
5410000
Annuals > 3 > balance Sheet > long Term Debt
5644000
Annuals > 3 > balance Sheet > total Liabilities
40658000
Annuals > 3 > balance Sheet > equity
15990000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-28617000
Annuals > 3 > cash Flow > depreciation
928000
Annuals > 3 > cash Flow > change In Working Capital
4841000
Annuals > 3 > cash Flow > cash From Operations
-17139000
Annuals > 3 > cash Flow > capital Expenditures
32000
Annuals > 3 > cash Flow > cash From Investing
-16000
Annuals > 3 > cash Flow > cash From Financing
23739000
Annuals > 3 > cash Flow > net Change In Cash
6345000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.633812287555388
Annuals > 3 > ratios > PB
0.5367809592995622
Annuals > 3 > ratios > ROE
-178.96810506566604
Annuals > 3 > ratios > ROA
-50.51722920491456
Annuals > 3 > ratios > FCF
-17171000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-3.254548900682335
Annuals > 3 > health Score
19
Valuation > metrics > PE
-0.054314282379852745
Valuation > metrics > PB
-0.7594998285990157
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
21.699993770634773
Profitability > metrics > ROA
-256.70596904937366
Profitability > metrics > Net Margin
-145.14583333333334
Profitability > final Score
40
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-3.255074040225821
Risk > final Score
17
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.11287026249530782
Liquidity > metrics > Quick Ratio
0.11287026249530782
Liquidity > final Score
16
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
70
Prev Profitabilities > 1
40
Prev Profitabilities > 2
24
Prev Risks > 0
-24
Prev Risks > 1
-2
Prev Risks > 2
10
Prev Liquidities > 0
23
Prev Liquidities > 1
78
Prev Liquidities > 2
78
Updated At
2026-01-20T21:56:16.548Z
Earnings History > 0 > period
2021-03-31
Earnings History > 0 > report Date
2021-06-30
Earnings History > 0 > date
2021-03-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
EUR
Earnings History > 0 > eps Actual
-0.1124
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
-0.1124
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2020-12-31
Earnings History > 1 > report Date
2021-03-09
Earnings History > 1 > date
2020-12-31
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
EUR
Earnings History > 1 > eps Actual
-0.1111
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-0.1111
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2020-09-30
Earnings History > 2 > report Date
2020-12-31
Earnings History > 2 > date
2020-09-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
EUR
Earnings History > 2 > eps Actual
-0.3254
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.3254
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2020-06-30
Earnings History > 3 > report Date
2020-07-30
Earnings History > 3 > date
2020-06-30
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
EUR
Earnings History > 3 > eps Actual
-0.3123
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
-0.3123
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2020-03-31
Earnings History > 4 > report Date
2020-06-30
Earnings History > 4 > date
2020-03-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
EUR
Earnings History > 4 > eps Actual
-0.2515
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
-0.2515
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2019-12-31
Earnings History > 5 > report Date
2020-03-11
Earnings History > 5 > date
2019-12-31
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
EUR
Earnings History > 5 > eps Actual
-0.2466
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
-0.2466
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2019-09-30
Earnings History > 6 > report Date
2019-12-31
Earnings History > 6 > date
2019-09-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
EUR
Earnings History > 6 > eps Actual
-0.26
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
-0.26
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2019-06-30
Earnings History > 7 > report Date
2019-07-24
Earnings History > 7 > date
2019-06-30
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
EUR
Earnings History > 7 > eps Actual
-0.2527
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
-0.2527
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2019-03-31
Earnings History > 8 > report Date
2019-04-23
Earnings History > 8 > date
2019-03-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
EUR
Earnings History > 8 > eps Actual
-0.3591
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
-0.3591
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2018-12-31
Earnings History > 9 > report Date
2019-03-31
Earnings History > 9 > date
2018-12-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
EUR
Earnings History > 9 > eps Actual
-0.3526
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
-0.3526
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2018-09-30
Earnings History > 10 > report Date
2018-10-24
Earnings History > 10 > date
2018-09-30
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
EUR
Earnings History > 10 > eps Actual
-0.5055
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
-0.5055
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2018-06-30
Earnings History > 11 > report Date
2018-07-24
Earnings History > 11 > date
2018-06-30
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
EUR
Earnings History > 11 > eps Actual
-0.5122
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
-0.5122
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2018-03-31
Earnings History > 12 > report Date
2018-06-30
Earnings History > 12 > date
2018-03-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
EUR
Earnings History > 12 > eps Actual
-0.2792
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-0.2792
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2017-12-31
Earnings History > 13 > report Date
2018-02-27
Earnings History > 13 > date
2017-12-31
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
EUR
Earnings History > 13 > eps Actual
-0.2963
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-0.2963
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2017-09-30
Earnings History > 14 > report Date
2017-10-25
Earnings History > 14 > date
2017-09-30
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
EUR
Earnings History > 14 > eps Actual
-0.348
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-0.348
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2017-06-30
Earnings History > 15 > report Date
2017-07-27
Earnings History > 15 > date
2017-06-30
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
EUR
Earnings History > 15 > eps Actual
-0.3428
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
-0.3428
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2017-03-31
Earnings History > 16 > report Date
2017-06-30
Earnings History > 16 > date
2017-03-31
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
EUR
Earnings History > 16 > eps Actual
-0.2916
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
-0.2916
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2016-12-31
Earnings History > 17 > report Date
2017-03-12
Earnings History > 17 > date
2016-12-31
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
EUR
Earnings History > 17 > eps Actual
-0.2733
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
-0.2733
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2016-09-30
Earnings History > 18 > report Date
2016-10-12
Earnings History > 18 > date
2016-09-30
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
EUR
Earnings History > 18 > eps Actual
-0.3555
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
-0.3555
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2016-06-30
Earnings History > 19 > report Date
2016-07-12
Earnings History > 19 > date
2016-06-30
Earnings History > 19 > before After Market
BeforeMarket
Earnings History > 19 > currency
EUR
Earnings History > 19 > eps Actual
-0.3794
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
-0.3794
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2016-03-31
Earnings History > 20 > report Date
2016-06-30
Earnings History > 20 > date
2016-03-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
EUR
Earnings History > 20 > eps Actual
-0.3801
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-0.3801
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2015-12-31
Earnings History > 21 > report Date
2016-03-31
Earnings History > 21 > date
2015-12-31
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
EUR
Earnings History > 21 > eps Actual
-0.3898
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
-0.3898
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2015-09-30
Earnings History > 22 > report Date
2015-12-31
Earnings History > 22 > date
2015-09-30
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
EUR
Earnings History > 22 > eps Actual
-0.3629
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
-0.3629
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2015-06-30
Earnings History > 23 > report Date
2015-09-30
Earnings History > 23 > date
2015-06-30
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
EUR
Earnings History > 23 > eps Actual
-0.3729
Earnings History > 23 > eps Estimate
0
Earnings History > 23 > eps Difference
-0.3729
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2015-03-31
Earnings History > 24 > report Date
2015-06-30
Earnings History > 24 > date
2015-03-31
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
EUR
Earnings History > 24 > eps Actual
-0.2873
Earnings History > 24 > eps Estimate
0
Earnings History > 24 > eps Difference
-0.2873
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2014-12-31
Earnings History > 25 > report Date
2015-03-31
Earnings History > 25 > date
2014-12-31
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
EUR
Earnings History > 25 > eps Actual
-0.2771
Earnings History > 25 > eps Estimate
0
Earnings History > 25 > eps Difference
-0.2771
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2014-09-30
Earnings History > 26 > report Date
2014-12-31
Earnings History > 26 > date
2014-09-30
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
EUR
Earnings History > 26 > eps Actual
-0.2932
Earnings History > 26 > eps Estimate
0
Earnings History > 26 > eps Difference
-0.2932
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2014-06-30
Earnings History > 27 > report Date
2014-09-30
Earnings History > 27 > date
2014-06-30
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
EUR
Earnings History > 27 > eps Actual
-0.3057
Earnings History > 27 > eps Estimate
0
Earnings History > 27 > eps Difference
-0.3057
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2014-03-31
Earnings History > 28 > report Date
2014-06-30
Earnings History > 28 > date
2014-03-31
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
EUR
Earnings History > 28 > eps Actual
-0.1899
Earnings History > 28 > eps Estimate
0
Earnings History > 28 > eps Difference
-0.1899
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2013-12-31
Earnings History > 29 > report Date
2014-03-31
Earnings History > 29 > date
2013-12-31
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
EUR
Earnings History > 29 > eps Actual
-0.1912
Earnings History > 29 > eps Estimate
0
Earnings History > 29 > eps Difference
-0.1912
Earnings History > 29 > surprise Percent
-
GenSight Biologics S.A., a clinical-stage biotechnology company, discovers, develops, and commercializes novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system. The company develops its products through gene therapy-based mitochondrial targeting sequence and optogenetics technology platforms. Its lead product candidates include LUMEVOQ, a recombinant AAV2-based gene therapy, which is in Phase III clinical trials for the treatment of leber hereditary optic neuropathy caused by a mutated ND4 gene; and GS030, which is in Phase I/II clinical trial for the treatment of retinitis pigmentosa and dry age-related macular degeneration. The company is also developing products that are in preclinical stage targeting ophthalmic and neurodegenerative diseases. It has license agreements with Sorbonne Université, CNRS, Inserm and SATT Lutech; Inserm Transfert S.A, Genethon, and Harvard; Massachusetts Institute of Technology; Novartis Pharma AG; Sorbonne University, Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale and Satt Lutech; Association Française contre les Myopathies, Inserm Transfert S.A; and non-exclusive license agreement with Adverum Biotechnologies. The company was incorporated in 2012 and is headquartered in Paris, France.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 0.00% of the total shares of GenSight Biologics S.A
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2021-03-31
EPS Actual
-0.1124
EPS Estimate
0
EPS Difference
-0.1124
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.